Strain Information | |
|---|---|
| Image | |
| BRC No. | RBRC02287 |
| Type | Targeted Mutation and Transgene |
| Species | Mus musculus |
| Strain name | C57BL/6-St3gal4<tm1.2Bsi> Tg(CAG-flp)1Bsi |
| Former Common name | ST34(#9 CAGflep)C57BL/6J, #9 CAGflep |
| H-2 Haplotype | |
| ES Cell line | MS12 [C57BL/6] |
| Background strain | C57BL/6JJcl |
| Appearance | |
| Strain development | |
| Strain description | |
| Colony maintenance | |
| References | Sialyltransferase ST3Gal IV deletion protects against temporal lobe epilepsy. Paitoon Srimontri, Shogo Endo, Toshiro Sakamoto, Yoshiaki Nakayama, Akira Kurosaka, Shigeyoshi Itohara, Yoshio Hirabayashi, Keiko Kato J. Neurochem., 131(5):675-87 (2014). 25066807 |
Health Report | |
|---|---|
| Examination Date / Room / Rack | |
Gene | |||||||
|---|---|---|---|---|---|---|---|
| Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
| Frt | yeast FRT (flippase recombination target) site | 9 | Frt | ||||
| St3gal4 MGI:1316743 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 | 9 | St3gal4<tm1.2Bsi> | targeted mutation 1.2, RIKEN BSI | |||
| loxP | phage P1 loxP | 9 | loxP | ||||
| loxP | phage P1 loxP | 9 | loxP | ||||
| FLP | yeast flippase recombinase | UN | FLP | CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA) | |||
Phenotype | |
|---|---|
| Phenotype annotation from literatures by Mammalian phenotype ontology | more 5 phenotypes |
| Detailed phenotype data | |
Ordering Information | |
|---|---|
| Donor DNA | マウス ST3Gal IV(欠損), CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA), 酵母 FLP組換え酵素遺伝子, 酵母 FRT, P1 ファージ loxP |
| Research application | Cre/loxP system FLP/frt system Metabolism Research Mouse Models for Human Disease |
| Specific Term and Conditions | No specific terms and conditions. (The DEPOSITOR waives its own rights under any patents, intellectual property, or other proprietary rights with respect to the results to be obtained by use of the BIOLOGICAL RESOURCE.) |
| Depositor | Yoshio Hirabayashi (RIKEN) |
| Strain Status | Frozen embryos |
| Strain Availability | |
| Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
|---|
| No Data |